H Dobbs - IVH Independent Trustee
| IVH Etf | USD 11.18 0.00 0.00% |
| Age | 65 |
| Tenure | 5 years |
| Phone | 215-255-1200 |
| Web | https://www.ivyfunds.com/products-performance/mutual-funds/ivy-closed-end-funds/high-income-opportunities/991 |
H Dobbs Latest Insider Activity
Tracking and analyzing the buying and selling activities of H Dobbs against IVH etf is an integral part of due diligence when investing in IVH. H Dobbs insider activity provides valuable insight into whether IVH is net buyers or sellers over its current business cycle. Note, IVH insiders must abide by specific rules, including filing SEC forms every time they buy or sell IVH'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
H Dobbs over two weeks ago Insider Trading |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| CFA CFA | Eaton Vance Senior | 44 | |
| Peter Finlay | Cion Investment Corp | 58 | |
| A Murphy | Eaton Vance Senior | N/A | |
| Kimberly Roessiger | Eaton Vance Senior | 36 | |
| Valerie Naratil | Blackstone Gso Strategic | 32 | |
| CFA CFA | The Gabelli Equity | 80 | |
| Stayce Harris | Blackrock International Growth | 62 | |
| Valerie Naratil | Blackstone Gso Long | 32 | |
| J Holloman | BlackRock Floating Rate | 66 | |
| W Kester | BlackRock Floating Rate | 70 | |
| Denise Keefe | First Trust Senior | N/A | |
| Alan Oshiki | Triplepoint Venture Growth | N/A | |
| F Drummond | Allianzgi Convertible Income | 58 | |
| Jeanne Kelly | Western Asset Investment | 70 | |
| Mark JD | Cion Investment Corp | 51 | |
| Fred Jensen | Western Asset Investment | 58 | |
| Michelle Green | Eaton Vance Senior | N/A | |
| Justine Abbadessa | Eaton Vance Senior | N/A | |
| Catherine Lynch | Blackrock Debt Strategies | 60 | |
| Jennifer Flynn | Eaton Vance Senior | N/A | |
| Earl Hedin | Cion Investment Corp | 64 | |
IVH Money Managers
| Daniel Geatens, Senior Vice President Treasurer | ||
| Richard Salus, Chief Financial Officer, Senior Vice President | ||
| Philip Shipp, Assistant Secretary | ||
| James Gressett, Independent Trustee | ||
| Christianna Wood, Independent Trustee | ||
| James Concannon, independent trustee | ||
| Jerome Abernathy, Independent Trustee | ||
| Joseph Kauten, Principal Financial Officer, Principal Accounting Officer, Vice President Treasurer | ||
| Michael Smith, Independent Trustee | ||
| John Fry, Independent Trustee | ||
| Sandra Lawrence, Independent Trustee | ||
| H Dobbs, Independent Trustee | ||
| Scott Schneider, Chief Compliance Officer, Vice President | ||
| Thomas Whitford, Independent Trustee | ||
| David Connor, Senior Vice President General Counsel, Secretary | ||
| Edward Tighe, Independent Trustee | ||
| Ann Borowiec, Independent Trustee | ||
| Joseph Chow, Independent Trustee | ||
| Frank Ross, independent trustee | ||
| Shawn Lytle, President, Chief Executive Officer, Trustee | ||
| Jennifer Dulski, Secretary | ||
| Frances SevillaSacasa, Independent Trustee | ||
| Janet Yeomans, Independent Trustee | ||
| Glendon Johnson, Independent Trustee | ||
| Joseph Harroz, Independent Chairman of the Board of Trustees | ||
| Thomas Bennett, Independent Chairman of Board of Trustees | ||
| Henry Herrmann, President Trustee | ||
| Philip Sanders, President, Trustee |
IVH Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IVH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 16.57 M | |||
| Shares Owned By Institutions | 53.69 % | |||
| Number Of Shares Shorted | 19.34 K | |||
| Price To Earning | 208.40 X | |||
| Short Ratio | 0.38 X | |||
| Earnings Per Share | 0.05 X | |||
| Number Of Employees | 13 | |||
| Beta | 0.51 | |||
| Market Capitalization | 178.71 M | |||
| Five Year Return | 8.77 % |
Currently Active Assets on Macroaxis
When determining whether IVH offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IVH's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ivh Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ivh Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
The market value of IVH is measured differently than its book value, which is the value of IVH that is recorded on the company's balance sheet. Investors also form their own opinion of IVH's value that differs from its market value or its book value, called intrinsic value, which is IVH's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IVH's market value can be influenced by many factors that don't directly affect IVH's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IVH's value and its price as these two are different measures arrived at by different means. Investors typically determine if IVH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IVH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.